BGM
BNTC icon

Burkehill Global Management’s Benitec Biopharma BNTC Stock Holding History

Burkehill Global Management’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Hold
150,000
– – 0.07% 130
2026
Q1 		$1.6M Hold
150,000
– – 0.08% 138
2025
Q4 		$2.02M Buy
+150,000
New +$2.07M 0.13% 118

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Burkehill Global Management's BNTC Position: Q2 2026 in Review

Burkehill Global Management held its Benitec Biopharma (BNTC) position steady in Q2 2026 at 150,000 shares worth $2.01M. The position accounts for 0.07% of the portfolio, ranked #130.

Burkehill Global Management first reported a position in BNTC in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.02M in Q4 2025. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Burkehill Global Management held 150,000 shares of Benitec Biopharma worth $2.01M as of Q2 2026.
  • Burkehill Global Management left its Benitec Biopharma share count unchanged in Q2 2026.
  • Benitec Biopharma made up 0.07% of Burkehill Global Management's portfolio in Q2 2026, its #130 holding.
  • Burkehill Global Management first reported a position in Benitec Biopharma in Q4 2025 and has held it in 3 quarters since.
  • Burkehill Global Management's Benitec Biopharma position peaked at $2.02M in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.